Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy Read more
Ribobay Pharma boosts CRDMO offerings with Cytiva’s first FlexFactory platform for oligonucleotides Read more
Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles Read more
Astraveus awarded €10.4 million grant by the French government as part of France 2030 investment plan Read more